Investor Tries To Stop LabCorp's $85M Orchid Buyout
Laboratory Corp. of America Holdings' plan to buy DNA testing company Orchid Cellmark Inc. for $85 million spurred a shareholder class action in New Jersey on Monday claiming the expedited deal...To view the full article, register now.
Already a subscriber? Click here to view full article